Opioid Education for Emergency Physicians 2022-2025

This course is designed to provide the practitioner with a didactic review of information pertaining to opioid prescribing in the emergency department and is required for all new ED physicians.

This course is in alignment with the regional Opioid Initiative, California Medical Board recommendations, and with TPMG's Emergency Medicine Opioid Workflow and AFM Chronic Opioid Therapy workflows.

Please launch the course in Chrome.

To begin, click the “Register” tab and then select a module.

    Target Audience

    Emergency Physicians

    Learning Objectives

    Module 1: Scope and Risk

    • Identify the scope of the opioid problem nationally.
    • Reduce risks to patients, families, communities, providers, and the medical group from opioids.
    • Be prepared to implement the Emergency Medicine Opioid workflow and model of care for opioid prescribing at Kaiser Permanente.

    Module 2: Emergency Medicine Opioid Workflow

    • Implement consistent assessment of risks and benefits, special considerations, and red flags for opioid treatment for non-cancer pain.
    • Implement treatment decisions that align with recommendations for new pain complaints, recurrent pain complaints, and patients with red flags.
    • Utilize KPHC and assessment tools.
    • Effectively communicate treatment plans, risks, benefits, and therapy goals to patients.

    Module 3: ER/LA Opioid Characteristics and Management

    • Integrate general and product-specific information about extended-release long-acting opioid analgesics into prescribing decisions and treatment planning.
    • Counsel patients on the safe use of opioids.


    • Centers for Disease Control and Prevention: National Vital Statistics System Mortality Statistics (www.cdc.gov/nchs/nvss/deaths.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fnchs%2Fdeaths.htm)
    • The Commonwealth Fund: “It’s Really, Truly Everywhere”: How the Opioid Crisis Worsened with COVID-19 (https://www.commonwealthfund.org/publications/podcast/2021/jun/its-really-truly-everywhere-how-opioid-crisis-worsened-covid-19)
    • drugpolicy.org: Drug Overdose (https://drugpolicy.org/issues/drug-overdose)
    • Substance Abuse and Mental Health Services Administration: Treatment Episode Data Set (TEDS) 2005 – 2015; National Admissions to Substance Abuse Treatment Services (www.samhsa.gov/data/report/treatment-episode-data-set-teds-2005-2015-national)
    • Collaborative for REMS Education (http://core-rems.org/)
    • ER/LA Opioid REMS Selected Important Safety Information (https://opioidanalgesicrems.com/home.html)
    • Group Health’s Initiative To Avert Opioid Misuse And Overdose Among Patients With Chronic Noncancer Pain - PMC (www.ncbi.nlm.nih.gov/pmc/articles/PMC3286629/)
    • Department of Veterans Affairs (www.healthquality.va.gov/guidelines/Pain/cot/VADoDOTCPG022717.pdf)
    • Manchikanti, L., & Singh, A. (2008). Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician, 11(2 Suppl), S63-S88.(www.painphysicianjournal.com/current/pdf?article=OTgz&journal=42)
    • Medical Board of California Guidelines for Prescribing Controlled Substances for Pain (www.mbc.ca.gov/Download/Publications/pain-guidelines.pdf)
    • Medline Plus: “Opiate and opioid withdrawal” (https://medlineplus.gov/ency/article/000949.htm)
    • Morales ME, Yong RJ. Racial and Ethnic Disparities in the Treatment of Chronic Pain. Pain Med. 2021 Feb 4;22(1):75-90. doi: 10.1093/pm/pnaa427. PMID: 33367911
    Course summary
    Available credit: 
    • 3.00 AMA PRA Category 1 Credit(s)™
    • 3.00 Pain/EOL
    Course opens: 
    Course expires: 

    John Ludlow MD MBA FACEP, TPMG Clinical Lead, ED Behavioral Health and Substance Abuse Initiatives

    Moses Graubard, MD, (former) Regional ED Opioids Champions lead, ED/Oakland

    David Roth, MD ED/Walnut Creek

    Sameer Awsare, MD, Associate Executive Director, Region

    TPMG CME logo

    TPMG Physician Education and Development is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

    TPMG Physician Education and Development designates this enduring material for a total of 3.0 hours of AMA PRA Category 1 credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    While you are welcome to review this course multiple times, CME credit may only be claimed once.

    Release date: November 1, 2022
    Termination date: October 31, 2025

    This activity also meets the requirements for 3.0 hours of Pain Management and/or End-of-Life care.

    Available Credit

    • 3.00 AMA PRA Category 1 Credit(s)™
    • 3.00 Pain/EOL
    Please login or register to take this course.

    Required Hardware/software

    Chrome browser is recommended. Pop-up blockers should be disabled.